Check GMAT Club Decision Tracker for the Latest School Decision Releases https://gmatclub.com/AppTrack

 It is currently 29 May 2017, 01:36

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Events & Promotions

###### Events & Promotions in June
Open Detailed Calendar

# The pharmaceutical industry argues that because new drugs

Author Message
TAGS:

### Hide Tags

SVP
Joined: 16 Jul 2009
Posts: 1536
Schools: CBS
WE 1: 4 years (Consulting)
Followers: 44

Kudos [?]: 1203 [0], given: 2

The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

24 May 2010, 16:32
4
This post was
BOOKMARKED
00:00

Difficulty:

35% (medium)

Question Stats:

72% (02:05) correct 28% (01:18) wrong based on 368 sessions

### HideShow timer Statistics

The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.

Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?

(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.
[Reveal] Spoiler: OA

_________________

The sky is the limit
800 is the limit

GMAT Club Premium Membership - big benefits and savings

If you have any questions
New!
Senior Manager
Affiliations: SPG
Joined: 15 Nov 2006
Posts: 327
Followers: 16

Kudos [?]: 751 [0], given: 28

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

25 May 2010, 00:00

IMO B

In B we give credibility to the claim of the pharmaceutical industry. The 10 year period required for the clinical tests to complete is the reason why the patent is held for 20 years. Thus, B is the best choice to support their claim.

_________________

press kudos, if you like the explanation, appreciate the effort or encourage people to respond.

SVP
Joined: 17 Feb 2010
Posts: 1507
Followers: 19

Kudos [?]: 630 [0], given: 6

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

27 May 2010, 11:14
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection. - irrelevant

(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. - correct

(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry. - we are not talking abt other industries

(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. - this actually weakens the phramaceutical industry's claim.

(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective. - we are not talking abt other industries
Joined: 19 Feb 2010
Posts: 397
Followers: 22

Kudos [?]: 186 [0], given: 76

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

28 May 2010, 15:02
1
This post was
BOOKMARKED
noboru wrote:
The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.

A. Other industries not the concern here.
B. That could be a difference with other industries, and make a good point why this specific industry needs a longer term of protection compared to other industries.
C. Doesn't support the pharm. industry.
D. Doesn't support the pharm. industry.
E. Doesn't support the pharm. industry.
Manager
Joined: 04 May 2009
Posts: 67
Location: Astoria, NYC
Followers: 1

Kudos [?]: 11 [0], given: 1

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

28 May 2010, 15:17
noboru wrote:
The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry’s argument against the challenge made above?
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.

I think B is the only one that further supports the claim by pharmaceutical companies that patent protections should be extended further than 20 years. The fact that it takes 10 years to finish clinical trials which is half the time that patents are protected for.
Manager
Joined: 14 Apr 2010
Posts: 222
Followers: 3

Kudos [?]: 185 [0], given: 1

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

09 Jun 2010, 20:00
"in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary."
Is it asking for an answer that supports that extension is unnecessary?? If so then why not A??
SVP
Joined: 16 Jul 2009
Posts: 1536
Schools: CBS
WE 1: 4 years (Consulting)
Followers: 44

Kudos [?]: 1203 [0], given: 2

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

27 Dec 2010, 16:27
OA is B.

Of the 20 years, only half are effective so it is ok for these companies to ask for an extension.
_________________

The sky is the limit
800 is the limit

GMAT Club Premium Membership - big benefits and savings

Verbal Forum Moderator
Joined: 31 Jan 2010
Posts: 488
WE 1: 4 years Tech
Followers: 13

Kudos [?]: 149 [0], given: 149

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

29 Dec 2010, 00:35
Is this a GMAT Prep question ?
_________________

My Post Invites Discussions not answers
Try to give back something to the Forum.I want your explanations, right now !

SVP
Joined: 16 Jul 2009
Posts: 1536
Schools: CBS
WE 1: 4 years (Consulting)
Followers: 44

Kudos [?]: 1203 [0], given: 2

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

29 Dec 2010, 05:24
mundasingh123 wrote:
Is this a GMAT Prep question ?

yes it is
_________________

The sky is the limit
800 is the limit

GMAT Club Premium Membership - big benefits and savings

Verbal Forum Moderator
Joined: 31 Jan 2010
Posts: 488
WE 1: 4 years Tech
Followers: 13

Kudos [?]: 149 [0], given: 149

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

29 Dec 2010, 05:45
noboru wrote:
mundasingh123 wrote:
Is this a GMAT Prep question ?

yes it is

Hi can you Please tag the source especially if its GMATPREP .I thought You always posted LSAT Questions.Thanks
_________________

My Post Invites Discussions not answers
Try to give back something to the Forum.I want your explanations, right now !

SVP
Joined: 16 Jul 2009
Posts: 1536
Schools: CBS
WE 1: 4 years (Consulting)
Followers: 44

Kudos [?]: 1203 [0], given: 2

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

29 Dec 2010, 07:51
mundasingh123 wrote:
noboru wrote:
mundasingh123 wrote:
Is this a GMAT Prep question ?

yes it is

Hi can you Please tag the source especially if its GMATPREP .I thought You always posted LSAT Questions.Thanks

Yes. I usually post LSAT question (I promise more very soon!). This one was an exception!
_________________

The sky is the limit
800 is the limit

GMAT Club Premium Membership - big benefits and savings

Manager
Joined: 17 Dec 2010
Posts: 97
Location: Australia
GMAT 1: 690 Q48 V37
GPA: 3.37
WE: Engineering (Consulting)
Followers: 1

Kudos [?]: 24 [0], given: 15

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

29 Dec 2010, 22:23
Booya! B it is
_________________

Kudos always appreciated if my post helped you

Manager
Joined: 02 Oct 2010
Posts: 153
Followers: 2

Kudos [?]: 42 [0], given: 29

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

13 Jan 2011, 23:33
This is an OG 12 Question. and the OA there is also B.
Current Student
Joined: 08 Jan 2009
Posts: 326
GMAT 1: 770 Q50 V46
Followers: 25

Kudos [?]: 146 [0], given: 7

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

14 Jan 2011, 03:33
B. Definitely strengthens their argument.

Posted from my mobile device
Current Student
Joined: 27 Jul 2010
Posts: 98
GMAT 1: 740 Q50 V40
Followers: 1

Kudos [?]: 15 [0], given: 9

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

14 Jan 2011, 03:38
I also think is b; it logically supports the extension of the patent
Manager
Status: GMAT in 4 weeks
Joined: 28 Mar 2010
Posts: 181
GPA: 3.89
Followers: 2

Kudos [?]: 153 [0], given: 25

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

12 Apr 2011, 13:08
I think option E needs to be considered. It states that in other new industries patent protection is often very ineffective. So they dont bother asking for extension.
_________________

If you liked my post, please consider a Kudos for me. Thanks!

Senior Manager
Joined: 12 Oct 2009
Posts: 264
Followers: 5

Kudos [?]: 177 [0], given: 4

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

12 Apr 2011, 15:53
B
Senior Manager
Joined: 25 Nov 2011
Posts: 256
Location: India
Concentration: Technology, General Management
GPA: 3.95
WE: Information Technology (Computer Software)
Followers: 4

Kudos [?]: 183 [1] , given: 20

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

18 Jan 2012, 09:38
1
KUDOS
seekmba wrote:
(A) No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection. - irrelevant

(B) Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete. - correct

(C) There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry. - we are not talking abt other industries

(D) An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug. - this actually weakens the phramaceutical industry's claim.

(E) Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective. - we are not talking abt other industries

IMO, D is a strong contender.
Assume that company C1 gets a patent and brings a product to the market. Immediately another company C2 produces a similar drug (but complies with the law as per D). Because for the company C2 there is no research cost and less development cost, C2 can bring the drug for lesser price compared to C1's. Hence C1 is forced to slash its price as well, which means they are not able to recoup development cost in later sales. This fact is stated in the first line of the argument. Hence D supports, but does not weakens.

But B is better than D, because if patent expiry time is extended, there will be less no. of companies who will be creating 'similar' drugs. Otherwise, there will be many companies who will create EXACT products immediately after the patent expiry.
_________________

-------------------------
-Aravind Chembeti

Director
Status: Enjoying the GMAT journey....
Joined: 26 Aug 2011
Posts: 720
Location: India
GMAT 1: 620 Q49 V24
Followers: 74

Kudos [?]: 529 [0], given: 264

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

20 Jan 2012, 20:11
+1 B.
_________________

Fire the final bullet only when you are constantly hitting the Bull's eye, till then KEEP PRACTICING.

A WAY TO INCREASE FROM QUANT 35-40 TO 47 : http://gmatclub.com/forum/a-way-to-increase-from-q35-40-to-q-138750.html

Q 47/48 To Q 50 + http://gmatclub.com/forum/the-final-climb-quest-for-q-50-from-q47-129441.html#p1064367

Three good RC strategies http://gmatclub.com/forum/three-different-strategies-for-attacking-rc-127287.html

GMAT Club Legend
Joined: 01 Oct 2013
Posts: 10303
Followers: 1000

Kudos [?]: 225 [0], given: 0

Re: The pharmaceutical industry argues that because new drugs [#permalink]

### Show Tags

22 Feb 2016, 18:31
Hello from the GMAT Club VerbalBot!

Thanks to another GMAT Club member, I have just discovered this valuable topic, yet it had no discussion for over a year. I am now bumping it up - doing my job. I think you may find it valuable (esp those replies with Kudos).

Want to see all other topics I dig out? Follow me (click follow button on profile). You will receive a summary of all topics I bump in your profile area as well as via email.
Re: The pharmaceutical industry argues that because new drugs   [#permalink] 22 Feb 2016, 18:31

Go to page    1   2    Next  [ 21 posts ]

Similar topics Replies Last post
Similar
Topics:
1 A pharmaceutical company tested a new diet drug over a two-month perio 4 07 Jan 2017, 06:27
5 A pharmaceutical company claims that its new drug promotes learning i 5 26 Feb 2016, 05:50
12 The pharmaceutical industry is fighting a losing battle: it 7 23 Oct 2015, 19:58
2 The lobbyists argued that because there is no statistical 8 20 Jul 2016, 11:38
1 The automobile industry in Country A argues that, because 18 02 Aug 2014, 02:41
Display posts from previous: Sort by